80 FR 60693 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 194 (October 7, 2015)

Page Range		60693-60694
FR Document		2015-25439

Federal Register, Volume 80 Issue 194 (Wednesday, October 7, 2015)

[Federal Register Volume 80, Number 194 (Wednesday, October 7, 2015)]
[Notices]
[Pages 60693-60694]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-25439]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel, Look AHEAD Brain MRI-2.
    Date: December 1, 2015.
    Time: 1:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference 
Call).
    Contact Person: Paul A. Rushing, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 747, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 
594-8895, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)


[[Page 60694]]


    Dated: October 1, 2015.
David Clary,
 Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-25439 Filed 10-6-15; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 80, No. 194 / Wednesday, October 7, 2015 / Notices 60693

FOR FURTHER INFORMATION CONTACT: RoC • Mountaintop removal mining (health physical substances, or mixtures
Nominations: Dr. Ruth Lunn, Director, impacts on surrounding communities) (collectively referred to as ‘‘substances’’)
ORoC; telephone (919) 316–4637; lunn@ • Neonicotinoid pesticides cause adverse non-cancer health
niehs.nih.gov. OHAT Nominations: Dr. • Fluoride (developmental outcomes. As part of these evaluations,
Kristina Thayer, Director, OHAT, neurotoxicity and endocrine NTP may also provide opinions on
telephone (919) 541–5021; thayer@ disruption) whether these substances might be of
niehs.nih.gov. Address for Dr. Lunn and Information on RoC nominations concern for causing adverse effects on
Dr. Thayer: DNTP, NIEHS, 111 T.W. should be submitted electronically on human health given what is known
Alexander Drive, P.O. Box 12233, the ORoC nomination page about toxicity and current human
Research Triangle Park, NC 27709. (http://ntp.niehs.nih.gov/go/rocnom) or exposure levels.
SUPPLEMENTARY INFORMATION: Request by email to lunn@niehs.nih.gov. Dated: October 1, 2015.
for Information: The NTP requests Information on OHAT nominations John R. Bucher,
information on nine substances: Six should be submitted electronically on Associate Director, National Toxicology
substances have been nominated for the OHAT nominated topics page Program.
possible review for future editions of the (http://ntp.niehs.nih.gov/go/763346) or [FR Doc. 2015–25434 Filed 10–6–15; 8:45 am]
RoC (see http://ntp.niehs.nih.gov/go/ to thayer@niehs.nih.gov. Public BILLING CODE 4140–01–P
rocnom) and three are under comments should include the
consideration by OHAT for evaluation submitter’s name, affiliation, sponsoring
of non-cancer health outcomes. (see organization (if any) along with DEPARTMENT OF HEALTH AND
http://ntp.niehs.nih.gov/go/763346). appropriate contact information HUMAN SERVICES
Specifically, NTP requests information (telephone and email). Written
on each substance regarding: (1) Data on information received in response to this National Institutes of Health
current production, use patterns, and notice will be posted on the NTP Web
human exposure; (2) published, site, and the submitter identified by National Institute of Diabetes and
ongoing, or planned studies related to name, affiliation, and/or sponsoring Digestive and Kidney Diseases; Notice
evaluating adverse health outcomes organization. of Closed Meeting
(e.g., cancer, development, Responses to this request for
reproductive, or immunological information are voluntary. This request Pursuant to section 10(d) of the
disorders); (3) scientific issues for information is for planning purposes Federal Advisory Committee Act, as
important for prioritizing and assessing only and is not a solicitation for amended (5 U.S.C. App.), notice is
adverse health outcomes; and (4) names applications or an obligation on the part hereby given of the following meeting.
of scientists with expertise or of the U.S. Government to provide The meeting will be closed to the
knowledge about the substance—please support for any ideas identified in public in accordance with the
include any bibliographic citations response to it. Please note that the U.S. provisions set forth in sections
when available. NTP will use this Government will not pay for the 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
information in determining which preparation of any information as amended. The grant applications and
substances to propose for formal health submitted or for its use. No proprietary, the discussions could disclose
hazard evaluations. classified, confidential, or sensitive confidential trade secrets or commercial
information should be included in your property such as patentable material,
Six Substances Nominated for Possible
response. and personal information concerning
Review for the RoC *
Background Information on ORoC: On individuals associated with the grant
Flame Retardants behalf of NTP, ORoC manages applications, the disclosure of which
preparation of the RoC following an
• Pentabromodiphenyl ether mixture would constitute a clearly unwarranted
established, four-part process (http:// invasion of personal privacy.
(DE–71)
ntp.niehs.nih.gov/go/rocprocess). The
• Tetrabromobisphenol A, CASRN 79– Name of Committee: National Institute of
RoC is a congressionally mandated,
94–7 Diabetes and Digestive and Kidney Diseases
science-based, public health report that Special Emphasis Panel, Look AHEAD Brain
Water Disinfection Byproducts identifies agents, substances, mixtures, MRI–2.
or exposures (collectively called
• Dibromoacetonitrile, CASRN 3252– Date: December 1, 2015.
‘‘substances’’) in our environment that Time: 1:00 p.m. to 2:00 p.m.
43–5
pose a cancer hazard for people in the Agenda: To review and evaluate grant
• Di- and tri-haloacetic acids (as a
United States. Published biennially, applications.
class); specifically, those haloacetic
each edition of the RoC is cumulative Place: National Institutes of Health, Two
acids with similar functional or
and consists of substances newly Democracy Plaza, 6707 Democracy
structural properties that may cause Boulevard, Bethesda, MD 20892, (Telephone
reviewed in addition to those listed in
similar health hazards Conference Call).
previous editions. Newly reviewed
Other substances with their recommended Contact Person: Paul A. Rushing, Ph.D.,
listing are reviewed and approved by Scientific Review Officer, Review Branch,
• Fluoride, CASRN 7681–49–4 DEA, NIDDK, National Institutes of Health,
the Secretary of Health and Human
• Vinylidene chloride, CASRN 5–35–4 Room 747, 6707 Democracy Boulevard,
Services. The 13th RoC, the latest
asabaliauskas on DSK5VPTVN1PROD with NOTICES

* Evaluations for the RoC may seek to Bethesda, MD 20892–5452, (301) 594–8895,
edition, was published on October 2, rushingp@extra.niddk.nih.gov.
list a new substance in the report, 2014 (available at http://
reclassify the listing status of a (Catalogue of Federal Domestic Assistance
ntp.niehs.nih.gov/go/roc13). The 14th Program Nos. 93.847, Diabetes,
substance already listed, or remove a RoC is under development. Endocrinology and Metabolic Research;
listed substance. Background Information on OHAT: 93.848, Digestive Diseases and Nutrition
Three substances are being considered On behalf of NTP, OHAT conducts Research; 93.849, Kidney Diseases, Urology
for OHAT evaluation of non-cancer literature-based evaluations to assess the and Hematology Research, National Institutes
health outcomes. evidence that environmental chemicals, of Health, HHS)

VerDate Sep<11>2014 18:12 Oct 06, 2015 Jkt 238001 PO 00000 Frm 00083 Fmt 4703 Sfmt 4703 E:\FR\FM\07OCN1.SGM 07OCN1

Document Created: 2015-12-15 08:49:00
Document Modified: 2015-12-15 08:49:00

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		December 1, 2015.
FR Citation		80 FR 60693

80 FR 60693 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 80, Issue 194 (October 7, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health